Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Rafat Abonour, MD
Indiana University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
153 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- William N. Wishard Memorial Hospital
Indianapolis, Indiana, United States
- Howard Community Hospital
Kokomo, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Reid Hospital & Health Care Services, Incorporated
Richmond, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- Mcfarland Clinic, Pc
Ames, Iowa, United States
- Genesis Medical Center - West Campus
Davenport, Iowa, United States
- Genesis Regional Cancer Center at Genesis Medical Center
Davenport, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- John Stoddard Cancer Center
Des Moines, Iowa, United States
- John Stoddard Cancer Center at Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates at Mercy Cancer Center
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Mercy Capitol Hospital
Des Moines, Iowa, United States
- Mercy Cancer Center at Mercy Medical Center - North Iowa
Mason City, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates, Llp
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Medical Oncology and Hematology Associates - West Des Moines
West Des Moines, Iowa, United States
- Cancer Center of Kansas, Pa - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas, Pa - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas, Pa - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas, Pa - Kingman
Kingman, Kansas, United States
- Southwest Medical Center
Liberal, Kansas, United States
- Cancer Center of Kansas, Pa - Newton
Newton, Kansas, United States
- Cancer Center of Kansas, Pa - Parsons
Parsons, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Oct 2004
- Primary completion
- 31 Dec 2011
- Completion
- 31 Aug 2012
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 16
- Registry id
- NCT00060346
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.